It is obvious that very few people are neutral here. You either love and believe in this company, or you are fully assured that they are a total scam. I see this name change as a complete success, and you immediately see it as a way to bilk new investors out of their money.
PHBC (formerly known as NVLX) has been executing beautifully under Kenneth Waggoner and his team. This is one more strategic move to position us all where we belong - in the arena of biotechnology without old distractions.
Remaining long and strong with PharmaCyte Biotech!
News 
Market Data 
Discover 
